View Clinical Trial (Medical Research Study)
Collecting and Storing Blood and Tissue Samples From Adult Patients With Cancer or Healthy Volunteers - NCT00919529-20892(Clinical Trial 297732)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
Bethesda |
|
State:
|
|
MD |
| Zip Code: |
|
20892 |
| Conditions: |
|
Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Precancerous/Nonmalignant Condition - Unspecified Adult Solid Tumor, Protocol Specific |
| Purpose: |
|
RATIONALE: Collecting and storing samples of tissue, blood, hair follicle , and bone marrow
from patients with cancer or healthy volunteers to study in the laboratory may help doctors
learn more about cancer and the development of drug resistance in patients.
PURPOSE: The purpose of this study is to collect and store tissue, blood, hair follicle, and
bone marrow samples from patients with cancer or healthy volunteers to be tested in the
laboratory.
|
| Study summary: |
|
OBJECTIVES:
- Create a repository of blood, serum, circulating cells, bone marrow, hair follicle, and
tumor or normal tissue samples from adult patients with cancer or healthy volunteers
that would allow development of assays for use in subsequent trials.
OUTLINE: Blood samples may be obtained from patients or healthy volunteers during the first
and subsequent visits. Tumor or normal tissue samples will be obtained if patients are
undergoing a surgical or biopsy procedure by fine needle aspirate, removal of pleural or
peritoneal fluid, or by excisional biopsy . Tumor or normal tissue (patients only) and hair
follicle samples may be requested of patients or healthy volunteers not undergoing a
surgical or biopsy procedure. Assays related to reversal of drug resistance may be performed
on samples provided (no germline or genetic testing will be performed on any tissues
collected).
PROJECTED ACCRUAL: A total of 100 patients will be accrued for this study. |
| Criteria: |
|
DISEASE CHARACTERISTICS:
- Diagnosed malignancy
- Advanced or refractory disease
- May or may not require surgical or biopsy procedure
- Patients not requiring biopsy for medical indication are allowed for the purpose
of obtaining research samples (e.g., blood, pleural fluid, or peritoneal fluid,
or biopsy samples, providing the biopsy or aspiration procedure is of minimal
risk [ i.e. fine needle aspirate, bone marrow aspirate, or excisional biopsy]).
- No radiology test for use in a procedure to collect tissue samples that would
not be otherwise used for appropriate medical indication
- Must be on or in the process of being evaluated in the Medical Oncology Clinic of the
National Cancer Institute for a research protocol
- Normal volunteers are allowed
PATIENT CHARACTERISTICS:
- ECOG performance status 0-3
- Not pregnant
- HIV negative
- No history of clotting disorders in healthy volunteers
PRIOR CONCURRENT THERAPY:
- Not specified |
|
|
|
|
|
|
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
December 30, 2009 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|